| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.86B | 18.02B | 18.17B | 17.83B | 17.16B | 19.54B |
| Gross Profit | 7.83B | 7.77B | 7.45B | 7.19B | 7.17B | 8.78B |
| EBITDA | 2.21B | 1.92B | 1.04B | 115.00M | 2.00B | 2.75B |
| Net Income | 162.00M | -702.00M | -466.00M | -1.61B | 3.32B | 1.19B |
Balance Sheet | ||||||
| Total Assets | 26.38B | 28.98B | 29.41B | 30.69B | 30.96B | 27.71B |
| Cash, Cash Equivalents and Short-Term Investments | 1.82B | 2.40B | 1.87B | 1.18B | 2.31B | 3.23B |
| Total Debt | 8.43B | 7.49B | 7.29B | 8.20B | 6.98B | 6.93B |
| Total Liabilities | 15.97B | 16.93B | 17.34B | 17.41B | 16.49B | 15.81B |
| Stockholders Equity | 10.38B | 12.01B | 12.03B | 13.25B | 14.44B | 11.87B |
Cash Flow | ||||||
| Free Cash Flow | 279.00M | 893.00M | 1.49B | -979.00M | 866.00M | 2.15B |
| Operating Cash Flow | 1.10B | 1.57B | 2.14B | -173.00M | 1.63B | 2.64B |
| Investing Cash Flow | -382.00M | -573.00M | -636.00M | -1.49B | -3.67B | -1.27B |
| Financing Cash Flow | 498.00M | -496.00M | -848.00M | 500.00M | -2.35B | 483.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $220.78B | 15.86 | ― | 1.86% | 6.37% | ― | |
| ― | $149.61B | 54.00 | ― | ― | 21.62% | 54.80% | |
| ― | $145.96B | 50.52 | 14.25% | 0.88% | 11.36% | -15.66% | |
| ― | $27.15B | 48.47 | 22.83% | ― | 9.30% | -14.95% | |
| ― | $25.86B | -33.44 | ― | 3.07% | -0.76% | -55.03% | |
| ― | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
| ― | $10.97M | -0.69 | -235.41% | ― | 0.36% | -17.20% |
Philips’ recent earnings call presented a balanced perspective, highlighting both positive developments and ongoing challenges. The company reported strong order intake growth and margin expansion, although certain segments experienced declines, and challenges in China persisted. Despite these hurdles, Philips remains optimistic about the second half of 2025, anticipating improved free cash flow and EBITA margins, even in the face of ongoing tariff impacts.
On July 29, 2025, Philips reported its second-quarter results, highlighting a 6% growth in comparable order intake and a 1% increase in group sales to EUR 4.3 billion. The company achieved an adjusted EBITA margin of 12.4%, driven by innovation and productivity improvements. Philips also raised its full-year outlook for adjusted EBITA margin and free cash flow. The company emphasized its commitment to innovation and patient care, supported by a multi-year agreement with the Indonesian Ministry of Health to expand access to cardiac, stroke, and cancer care. Philips’ strategic focus on AI-powered innovations and partnerships is enhancing its market position and operational performance.